These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11712862)

  • 21. Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis.
    Kato T; Miyakawa H; Ishibashi M
    J Autoimmun; 2004 May; 22(3):211-6. PubMed ID: 15041041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti LKM-1 antibodies and cryoglobulinemia in autoimmune chronic hepatitis and virus C hepatitis].
    Jirón MI; Ardiles A; Parra MA; Orellana J
    Rev Med Chil; 2000 Mar; 128(3):273-8. PubMed ID: 10962868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
    Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
    Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
    Todros L; Saracco G; Durazzo M; Abate ML; Touscoz G; Scaglione L; Verme G; Rizzetto M
    Hepatology; 1995 Nov; 22(5):1374-8. PubMed ID: 7590650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
    Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
    Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome autoantibody type 1.
    Iijima Y; Kato T; Miyakawa H; Ogino M; Mizuno M; Sugihara K; Ando T; Fujiwara K; Orito E; Ueda R; Mizokami M
    J Gastroenterol Hepatol; 2001 Jul; 16(7):782-8. PubMed ID: 11446887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection.
    Girardin F; Daali Y; Gex-Fabry M; Rebsamen M; Roux-Lombard P; Cerny A; Bihl F; Binek J; Moradpour D; Negro F; Desmeules J;
    J Viral Hepat; 2012 Aug; 19(8):568-73. PubMed ID: 22762141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis.
    Lapierre P; Johanet C; Alvarez F
    Eur J Immunol; 2003 Jul; 33(7):1869-78. PubMed ID: 12811847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.
    Löhr HF; Schlaak JF; Lohse AW; Böcher WO; Arenz M; Gerken G; Meyer Zum Büschenfelde KH
    Hepatology; 1996 Dec; 24(6):1416-21. PubMed ID: 8938173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LKM-positive autoimmune hepatitis in the western United States: a case series.
    Duchini A; McHutchison JG; Pockros PJ
    Am J Gastroenterol; 2000 Nov; 95(11):3238-41. PubMed ID: 11095348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.
    Bortolotti F; Muratori L; Jara P; Hierro L; Verucchi G; Giacchino R; Barbera C; Zancan L; Guido M; Resti M; Pedditzi S; Bianchi F; Gatta A
    J Pediatr; 2003 Feb; 142(2):185-90. PubMed ID: 12584542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients.
    Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P; Zajíc J
    Acta Virol; 2001 Feb; 45(1):7-11. PubMed ID: 11394582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
    Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
    J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.
    Peakman M; Lobo-Yeo A; Mieli-Vergani G; Davies ET; Mowat AP; Vergani D
    Clin Exp Immunol; 1987 Sep; 69(3):543-9. PubMed ID: 3665184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.
    Bogdanos DP; Lenzi M; Okamoto M; Rigopoulou EI; Muratori P; Ma Y; Muratori L; Tsantoulas D; Mieli- Vergani G; Bianchi FB; Vergani D
    Int J Immunopathol Pharmacol; 2004; 17(1):83-92. PubMed ID: 15000871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
    Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
    Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule.
    Ma Y; Thomas MG; Okamoto M; Bogdanos DP; Nagl S; Kerkar N; Lopes AR; Muratori L; Lenzi M; Bianchi FB; Mieli-Vergani G; Vergani D
    J Immunol; 2002 Jul; 169(1):277-85. PubMed ID: 12077255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.